Compare FINW & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINW | CNC |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.2M | 18.7B |
| IPO Year | 2021 | 2001 |
| Metric | FINW | CNC |
|---|---|---|
| Price | $18.42 | $39.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 17 |
| Target Price | $21.67 | ★ $40.06 |
| AVG Volume (30 Days) | 17.7K | ★ 7.1M |
| Earning Date | 01-29-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | $80,198,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $72.14 | $32.54 |
| Revenue Next Year | $47.30 | $0.19 |
| P/E Ratio | $17.21 | ★ N/A |
| Revenue Growth | ★ 14.76 | 14.57 |
| 52 Week Low | $13.49 | $25.08 |
| 52 Week High | $22.49 | $66.81 |
| Indicator | FINW | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 56.02 |
| Support Level | $17.07 | $38.02 |
| Resistance Level | $18.25 | $41.74 |
| Average True Range (ATR) | 0.51 | 1.29 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 82.17 | 47.33 |
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.